Clinical Trials on Paraproteinemias
Total 3729 results
-
First Affiliated Hospital of Zhejiang UniversityUnknownMultiple MyelomaChina
-
Asclepius Technology Company Group (Suzhou) Co....Unknown
-
Sun Pharma Advanced Research Company LimitedCompleted
-
Millennium Pharmaceuticals, Inc.Completed
-
Eli Lilly and CompanyCompleted
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Dana-Farber Cancer InstituteCompletedMultiple MyelomaUnited States
-
Sirtris, a GSK CompanyGlaxoSmithKlineTerminatedMultiple MyelomaUnited Kingdom, Denmark
-
Academia Nacional de MedicinaUnknownMonoclonal Gammopathy of Renal SignificanceArgentina
-
Masonic Cancer Center, University of MinnesotaNo longer available
-
Emory UniversityNovartis; University of Chicago; University of California, San Francisco; Amgen; Onyx... and other collaboratorsCompletedMultiple MyelomaUnited States
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
AbbVieTerminatedMultiple MyelomaUnited States, France, Germany, Spain
-
Janssen Scientific Affairs, LLCTerminated
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
Novartis PharmaceuticalsTerminated
-
Janssen Research & Development, LLCCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...Unknown
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Netherlands, Sweden, Denmark
-
Medical University of South CarolinaGenentech, Inc.CompletedMultiple MyelomaUnited States
-
Hellenic Society of HematologyJanssen PharmaceuticalsUnknown
-
AEterna ZentarisCompletedMultiple MyelomaUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...CompletedComparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple MyelomaMultiple MyelomaGermany
-
Henan Cancer HospitalThe Pregene (ShenZhen) Biotechnology Company, Ltd.Unknown
-
CelgeneCompletedPhase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Emory UniversityOnyx Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Vejle HospitalCompleted
-
Sigma Tau Research Switzerland SACompleted
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
Jinling Hospital, ChinaUnknownMultiple MyelomaChina
-
Yongping ZhaiUnknownMultiple MyelomaChina
-
Barbara Ann Karmanos Cancer InstituteEisai Inc.TerminatedMultiple MyelomaUnited States
-
University of MiamiTerminatedMultiple MyelomaUnited States
-
Genentech, Inc.Completed
-
University of ArkansasNational Institutes of Health (NIH)CompletedMultiple MyelomaUnited States
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
AmgenCompletedMultiple MyelomaGreece, Italy, Netherlands
-
AmgenCompleted
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
Merck Sharp & Dohme LLCCompleted
-
SCRI Development Innovations, LLCNovartisTerminated
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
CelgeneTerminatedMultiple MyelomaChina
-
Genentech, Inc.CompletedMultiple MyelomaUnited States
-
BayerWithdrawnMultiple MyelomaBelgium, Spain, Korea, Republic of, Taiwan, United States, Australia, Germany, Israel, Italy, Greece, Canada
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMultiple Myeloma
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan